CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss
Mice, Knockout
0301 basic medicine
Indoles
Cell Death
Cyclin-Dependent Kinase 2
Drug Resistance
Benzazepines
Lateral Line System
Mitochondria
Rats
3. Good health
Mice, Inbred C57BL
Small Molecule Libraries
03 medical and health sciences
Germ Cells
Hearing Loss, Noise-Induced
Cytoprotection
Cell Line, Tumor
Hair Cells, Auditory
Animals
Cisplatin
Reactive Oxygen Species
Protein Kinase Inhibitors
Research Articles
DOI:
10.1084/jem.20172246
Publication Date:
2018-03-07T12:25:21Z
AUTHORS (21)
ABSTRACT
Hearing loss caused by aging, noise, cisplatin toxicity, or other insults affects 360 million people worldwide, but there are no Food and Drug Administration–approved drugs to prevent or treat it. We screened 4,385 small molecules in a cochlear cell line and identified 10 compounds that protected against cisplatin toxicity in mouse cochlear explants. Among them, kenpaullone, an inhibitor of multiple kinases, including cyclin-dependent kinase 2 (CDK2), protected zebrafish lateral-line neuromasts from cisplatin toxicity and, when delivered locally, protected adult mice and rats against cisplatin- and noise-induced hearing loss. CDK2-deficient mice displayed enhanced resistance to cisplatin toxicity in cochlear explants and to cisplatin- and noise-induced hearing loss in vivo. Mechanistically, we showed that kenpaullone directly inhibits CDK2 kinase activity and reduces cisplatin-induced mitochondrial production of reactive oxygen species, thereby enhancing cell survival. Our experiments have revealed the proapoptotic function of CDK2 in postmitotic cochlear cells and have identified promising therapeutics for preventing hearing loss.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (68)
CITATIONS (88)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....